PACAPs-potential for bronchodilation.
Lindén
L
L
Lung Pharmacology Group, Department of Respiratory Medicine & Allergology, Göteborg University, Guldhedsgatan 10A, Gothenburg, SE-41346, Sweden.
D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D016084:Bronchoconstriction; D001993:Bronchodilator Agents / Q000494:pharmacology*; D006801:Humans; D009130:Muscle, Smooth / Q000187:drug effects / Q000502:physiology; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D009479:Neuropeptides / Q000494:pharmacology*; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D011651:Pulmonary Artery / Q000187:drug effects; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology*
C495401:ADCYAP1 protein, human; D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D009479:Neuropeptides; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D014665:Vasodilator Agents; D014660:Vasoactive Intestinal Peptide